Caring for Patients with Bleeding Disorders
Contact Hours: 2.5
Cost: $25.00
This instructional course has been designed for healthcare clinicians administering and/or caring for the patient with a bleeding disorder. Although the patient may receive long-term care at a physician’s office or Hemophilia Treatment Center, day-to-day care occurs at home, school, work, camp, etc. All clinicians involved in infusing antihemophilic agents and those caring for patients receiving these medications need a working knowledge of the diagnoses for which they are given, proper storage, preparation and administration, and disposal, as well as appropriate interventions, and the psychological implications of having these diseases and receiving treatment for them. Education-related specifically to bleeding disorders is crucial to the safe and effective care of these patients.
State Boards of Nursing have varying positions on the role of the LPN/LVN in the administration of infusion therapy, including the administration of antihemophilic agents. A link to each state board of nursing is
listed here. Competency requirements are obtained and maintained through the nurse’s employer, facility or institution.
Objectives
Upon completion of this course, the participant should be able to:
1. Describe the symptoms of bleeding disorders
2. Explain the factor deficiencies in Hemophilia A, Hemophilia B, and von
Willebrand disease
3. Describe R.I.C.E
4. Recognize antifibrolytic agents used to treat bleeding disorders
5. Describe at least two ramifications of bleeding disorders presented in this course
6. Identify at least three treatments used for patients with inhibitors
7. Identify at least two potential future treatments for bleeding disorders and their
potential advantages over current treatments
Curriculum
Chapter 1: Introduction
• Definition
• Symptoms
• History
• The coagulation cascade
Chapter 2: More Common Bleeding Disorders
• Factor VIII deficiency
• Factor IX deficiency
• Von Willebrand disease
Chapter 3: Treatment
• R.I.C.E.
• Prophylactic factor replacement
• Other medications/substances
Chapter 4: Less Common Factor Deficiencies
• Factor I
• Factor II
• Factor V
• Combined factor V/VIII
• Factor VII
• Factor X
• Factor XI
• Factor XII
• Factor XIII
Chapter 5: Ramifications of Bleeding Disorders
• Joint damage
• Pain
• Health-related quality of life
• Financial impact
• Social and emotional impact
Chapter 6: Inhibitors
• Definition
• Measuring inhibitors
• Treatment for patients with inhibitors
Bypassing products
PCCs and APCCs
Recombinant Factor VIIa
Other medications
Plasmapheresis
Immune tolerance induction
Chapter 7: The Future of Bleeding Disorder Treatment
• Fitusiran
• Concizumab
• B-domain depleted porcine FVIII
• Gene therapy
• Improved FVIII & FIX half-life
Chapter 8: The Role of the Nurse
Chapter 9: Treatment Administration
Chapter 10: References